HIGHLIGHTS
- who: A. Kuendgen from the (UNIVERSITY) have published the Article: Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification⠎an approach to classification of patients with t-MDS, in the Journal: (JOURNAL)
- what: In line with the essentially exploratory nature of the study, no adjustment for multiple testing was applied. The authors have demonstrated that the influence of cytogenetics is very high in t-MDS and the prognostic power of the cipssr is in t-MDS at least as good as in p-MDS, due to a high proportion of abnormal karyotypes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.